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Background: Individuals with posttraumatic stress disorder (PTSD) display reduced hippocampus size and impaired cognition. However,
studies on individuals with borderline personality disorder (BPD) are rare, and studies on trauma-exposed patients with BPD but without
PTSD are lacking. Methods: Twenty-four trauma-exposed women with BPD (10 with PTSD and 14 without) and 25 healthy controls under-
went 3-dimensional structural magnetic resonance imaging of the amygdala and hippocampus and a clinical and neuropsychological investi-
gation. Results: Compared with controls, patients with BPD and PTSD displayed significantly reduced amygdala  (34%) and hippocampus
(12%) size and significantly impaired cognition. Trauma-exposed patients with BPD but without PTSD also showed significantly reduced
amygdala (22%) and hippocampus (11%) size but normal cognition. Amygdala and hippocampus size did not differ significantly between
 patients with and without PTSD. Limitations: The sample sizes of trauma-exposed groups are relatively small. A larger sample size may
have revealed statistically significant differences in amygdala size between those with and without PTSD. Conclusion: Our results demon-
strate strong amygdala size reduction in trauma-exposed patients with BPD with or without PTSD, much exceeding that reported for trauma-
exposed individuals without BPD. Our data suggest that BPD is associated with small amygdala size. Furthermore, evidence is increasing
that amygdala and hippocampus size reduction is not only due to PTSD, but also to traumatic exposure.
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Introduction
Previous studies have suggested that posttraumatic stress
disorder (PTSD) is associated with small hippocampus size1,2
and reduced cognitive functions.3–7 Meta-analysis2 has re-
vealed minor size reductions of the left amygdala in patients
with PTSD and no amygdala size reduction in trauma-
 exposed patients without PTSD. Hippocampus size reduc-
tions covary with PTSD severity2 and cognitive deficits,3–5,7
suggesting that hippocampal damage may be a powerful
predictor for the severity and chronic character of PTSD.
Studies concerning amygdala or hippocampus size reduc-
tion in patients with borderline personality disorder (BPD) are
rare. So far, studies have used mixed samples, including pa-
tients with and without traumatic exposure and with and
without PTSD.8–13 A recent study14 reported strong amygdala
and hippocampus size reduction in individuals with BPD and
PTSD. However, detailed comparisons of trauma- exposed
 patients with BPD with and without PTSD are lacking.
The present study examined amygdala and hippocampus
volumes and cognitive functions in patients with BPD with
and without PTSD and healthy controls. The goals of our
study were to investigate whether trauma-exposed patients
with BPD but without PTSD display amygdala and hippocam-
pus size reduction and impaired cognition and to analyze how
cognitive deficits are related to amygdala and hippocampus
size in trauma-exposed individuals. We expected that trauma-
exposed patients with BPD but without PTSD would show re-
duced amygdala and hippocampus size and impaired cogni-
tion. We supposed that cognitive deficits of trauma-exposed
individuals would be related to small hippocampus size.
Methods
Participants
The sample comprised young female in-patients admitted to
the Asklepios Psychiatric Hospital, Göttingen, Germany. The
patients had BPD and had been exposed to severe childhood
sexual and physical abuse. We assessed patients within 3 weeks
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after admission to the hospital when they were in a clinically
stable phase.
We assessed all patients using a routine physical and neu-
rologic examination, magnetic resonance imaging (MRI) and
laboratory testing. We excluded patients with a history of
neurologic disease, electroencephalographic abnormalities or
pathological MRI signal (visual inspection of T1, T2 and fluid-
attenuated inversion recovery sequences), being indicative
for vascular or inflammatory diseases. We also excluded pa-
tients with psychotic disorders, bipolar disorder, current sub-
stance use disorders (Structured Clinical Interview for DSM-
IV [SCID-I]),15 or dissociative disorders (Structured Clinical
Interview for DSM-IV Dissociative Disorders  [SCID-D]).16
We compared trauma-exposed patients with healthy con-
trols matched for sex, age, height and years of education. We
recruited controls through an advertisement in a local news-
paper and leaflets distributed in the Hospital of the Univer-
sity of Göttingen and in town. We included only individuals
without a history of neurologic or psychiatric (as assessed by
the SCID-I)15 disorders.
We obtained written informed consent from all par-
ticipents after providing them with a complete description of
the study. The ethical committee of the medical faculty of the
University of Göttingen approved the study design.
Clinical and neuropsychological assessment
We investigated trauma-exposed patients using the SCID-I
and II15 and the SCID-D interviews.16 We used the Traumatic
Antecedent Questionnaire (TAQ)17 to assess neglect as well as
physical and sexual abuse experiences during childhood and
adolescence (ages 7–18 yr). We used the Impact of Events
Scale — Revised (IES-R)18 to assess PTSD symptoms. We eval-
uated a broad range of clinical symptoms using the Symptom
Checklist-90-Revised (SCL-90-R).19 We assessed depressive
symptoms using the Beck Depression Inventory (BDI).20 We
assessed alcohol consumption and alcohol-related clinical
symptoms using the Münchner Alkoholismus Test (MALT).21
We assessed intellectual, mnemonic and attentional func-
tion using the Wechsler Adult Intelligence Scale-Revised
(WAIS-R),22 the Wechsler Memory Scale-Revised (WMS-R),23
the Trail Making Test (TMT)24 and the subtest Attentional
Shift of the Testbatterie zur Aufmerksamkeitsprüfung (TAP).25
All diagnoses were established by consensus among at
least 2 psychiatrists (U.S. and the psychiatrist in charge)
 using the DSM-IV criteria and information obtained from the
SCID interviews. The diagnostic procedures have been
shown to be highly reliable.12 Among the trauma-exposed
participants with BPD, comorbid disorders included recur-
rent major depression, alcohol-related disorders and eating
disorders. Patients were on a stable dose of medication for at
least 3 weeks before the study; some were on antidepressants
and some occasionally received sedatives.
MRI assessment
We obtained MRI scans with a 1.5 T Philips Gyroscan ma-
chine in all participants using previously described tech-
niques.12,14 We performed volumetric analysis on the basis of
3-dimentional (3-D) MRI scans. We transferred the images to
a computer workstation and processed them using CURRY
software, version 4.5 (Neurosoft Inc.). We reformatted the
 images into continuous 1 mm–thick slices.
We calculated intracranial volume and total brain volume
with automated multistep algorithms and 3-D region growing
methods limited by grey value thresholds. Simultaneous 3-D
visualization of brain structures and manual tracing allowed a
precise identification and delineation of regions of interest
(ROIs). We separately disarticulated the amygdala and hip-
pocampus from surrounding tissue on coronal slices by means
of manual tracing according to a standardized protocol.26 We
separated the amygdala and hippocampus by 3-D visualiza-
tion of the alveus and the inferior horn of the lateral ventricle.
A single rater (C.L.), blind to the diagnosis, did the assessment.
To define intrarater reliability, the analyst reassessed 1 hemi-
sphere of 10 randomly chosen patients. The intraclass correla-
tion coefficients for this procedure were r = 0.94 for the amyg-
dala and r = 0.95 for the hippocampus.  Inter -rater reliabilities,
including that of this rater, have been published previously
(hippocampus, r = 0.96; amygdale, r = 0.96).12,27
Statistical analysis
We applied analyses of variance (ANOVA) and post-hoc
tests to compare differences between groups on demo-
graphic, clinical and cognitive variables and on intracranial
volume and brain:skull ratio. We corrected the ANOVA test-
ing subscales of neuropsychological and clinical instruments
for multiple testing (Bonferroni correction: α levels, TAQ and
IES-R = 0.016, SCL-R and WAIS-R = 0.025, WMS-R = 0.0125).
We assessed subgroups of trauma-exposed patients using the
Mann–Whitney U test. We compared amygdala and hip-
pocampus volumes of trauma-exposed groups and the con-
trol group using analyses of covariance (ANCOVA) with
group as the between-subject factor and hemisphere as the
within-subject factor and with adjustment for total brain vol-
ume. We also computed the ANCOVA with IQ as a further
covariate. We compared total brain volumes of all groups
 using ANCOVA with adjustment for intracranial volume.
We used multiple stepwise regression analyses with a signifi-
cance level for selecting variables of α = 0.05 to examine the
relations between amygdala and hippocampus volumes and
neuropsychological variables. We used left- and right-sided
amygdala and hippocampus volumes and total brain volume
as explanatory variables and neuropsychological test results
as dependent variables. All analyses were 2-tailed; we set the
level of statistical significance at p < 0.05. We performed sta-
tistical analyses using the Statistical Package for the Social
Sciences (SPSS for Windows, version 14.0).
Results
Participants
Our sample comprised 24 young female in-patients with BPD
who had been exposed to severe childhood sexual and
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 physical abuse and 25 healthy matched controls. Participant
characteristics are provided in Table 1. 
Trauma-exposed subgroups
Ten trauma-exposed patients met criteria for chronic PTSD
according to the DSM-IV. These patients were also included
in a previous report.14 The remaining 14 trauma- exposed pa-
tients confirmed criterion A, but did not meet criteria B–D of
the DSM-IV. Among these patients, few clinical symptoms
relating to criteria B–D were also present (Table 1, IES-R).
However, they were unable to determine whether these
symptoms developed as a result of a specific traumatic expo-
sure or whether they were also present before the trauma.
All trauma-exposed patients met criteria for BPD (SCID-II);
all had received the diagnosis of BPD based on clinical judg-
ment at the time of the assessment and at an earlier time. Nine-
teen patients met criteria for recurrent major depression; of
these, 7 had PTSD. Seven patients had alcohol- related disorders
(lifetime abuse, n = 3; lifetime dependence, n = 4); of these,
3 had PTSD. Ten patients had eating disorders (lifetime
anorexia, n = 3; lifetime bulimia, n = 3; current bulimia, n = 4);
of these, 4 had PTSD. Seven patients were on antidepressant
medications; 4 of them had PTSD). Five patients occasionally re-
ceived sedatives (diazepam or lorazepam); 3 of them had PTSD.
The trauma-exposed groups did not differ with respect to
age, height, education, disorder duration, depression sever-
ity, global psychological distress (SCL-90-R) and alcohol
consumption (Table 1). However, patients with PTSD re-
ported significantly more sexual abuse (TAQ) and stronger
intrusions (IES-R) than those without PTSD. The amount of
Table 1: Clinical and neuropsychological characteristics of trauma-exposed patients with borderline personality disorder with or without
posttraumatic stress disorder and healthy controls
Group; mean (SD)*
Variable BPD with PTSD (n = 10) BPD without PTSD (n = 14) Controls (n = 25) Statistical test p value
Age, [range] yr 32 (7) 32 (5) 33 (7) F2,46 = 0.2 0.85
[21–43] [26–39] [21–45]
Education, y 14 (2) 16 (3) 14 (2) F2,46 = 2.4 0.10
Handedness, left:right 0:10 2:12 0:25 Fisher exact test 0.12
Duration of disorder, yr 16 (7) 14 (9) t20 = 0.4 0.67
TAQ
Neglect 5.7 (1.6)¶ 5.1 (1.4)¶ 2.9 (0.9) F2,43 = 24.7 < 0.001
Physical abuse 5.4 (1.6)¶ 4.7 (2.1)¶ 2.3 (1.1) F2,41 = 16.9 < 0.001
Sexual abuse 6.0 (2.0)¶** 4.1 (2.3)¶ 2.0 (0.1) F2,42 = 24.0 < 0.001
IES-R
Intrusions 3.8 (0.8) 2.4 (0.9) t19 = 3.6 0.002
Avoidance 3.8 (1.5) 3.5 (0.8) t19 = 0.5 0.62
Hyperarousal 3.9 (0.9) 2.9 (1.1) t19 = 2.2 0.040
SCL-90-R
Global severity index 1.8 (0.6)¶ 1.6 (0.5)¶ 0.3 (0.3) F2,46 = 59.7 < 0.001
Positive symptom distress index 2.4 (0.6)¶ 2.4 (0.5)¶ 1.3 (0.4) F2,46 = 35.8 < 0.001
Beck Depression Inventory20 29 (11) 27 (8) t22 = 0.3 0.75
Münchner Alkoholismus Test21† 6 (7) 6 (6) t22 = 0.3 0.98
WAIS-R‡
Verbal IQ 94 (11)** 105 (14) 111 (13) F2,46 = 6.7 0.003
Performance IQ 94 (16)†† 104 (17) 116 (16) F2,46 = 7.0 0.002
WMS-R
Verbal memory 106 (10) 110 (10) 112 (14) F2,46 = 1.0 0.36
Visual memory 88 (14)¶** 109 (15) 118 (17) F2,46 = 12.2 < 0.001
Delayed recall 103 (15)‡‡ 116 (16) 119 (14) F2,46 = 4.1 0.023
Attention/concentration 80 (11) ¶§§ 100 (18) 102 (12) F2,46 = 9.9 < 0.001
Trail Making Test24
Part A, s 35 (10)¶** 24 (12) 21 (5) F2,46 = 9.2 < 0.001
Part B, s 65 (36) 49 (17) 45 (13) F2,46 = 3.1 0.06
TAP, attentional shift, ms§ 1304 (782)**†† 848 (217) 779 (125) F2,46 = 7.2 0.002
BPD = borderline personality disorder; IES-R = Impact of Events Scale — Revised;18 IQ = intelligence quotient; PTSD = posttraumatic stress disorder; SCL-90-R = Symptom Checklist-
90-Revised;19 SD = standard deviation; TAP = Testbatterie zur Aufmerksamkeitsprüfung;25 TAQ = Traumatic Antecedent Questionnaire;17 WAIS-R = Wechsler Adult Intelligence Scale —
Revised;22 WMS-R = Wechsler Memory Scale — Revised.23
*Unless otherwise indicated.
†The Münchner Alkoholismus Test is a clinician-administered rating scale: 0–5 = normal alcohol consumption, 6–10 = likely alcohol abuse, 11–52 = alcohol abuse or dependence.
‡IQ estimates on the Wechsler Adult Intelligence Scale — Revised were derived from Information, Similarities, Picture Completion and Block Design scores.
§The Testbatterie zur Aufmerksamkeitsprüfung involves 1-figure numbers and letters presented simultaneously on the left and right of a computer screen with the position of these stimuli
varying across trials. Participants have to press a left- or right-hand button corresponding to the position of the target stimulus (number or letter), which alternates between trials.
¶Significantly different from controls (p < 0.001; post-hoc test).
**Significantly different from trauma-exposed patients with BPD but without PTSD (p < 0.05; post-hoc test).
††Significantly different from controls (p < 0.01; post-hoc test).
‡‡Significantly different from controls (p < 0.05; post-hoc test).
§§Significantly different from trauma-exposed patients with BPD but without PTSD (p < 0.01; post-hoc test).
reported neglect and physical abuse (TAQ) did not differ be-
tween the 2 groups. Trauma-exposed patients taking  anti -
depressants (n = 7) did not differ from those not taking anti-
depressants (n = 17) with respect to brain measures or any
clinical or neuropsychological variables (Mann–Whitney 
U tests, p > 0.10). The same was true for patients who occa-
sionally took sedatives (n = 5) and those who did not (n = 19)
(p > 0.12).
Brain measures
Patients with PTSD had significantly smaller total brain vol-
umes and increased global atrophy (brain:skull ratio) when
compared with controls (Table 2). An overall 3 × 2
(group × hemisphere) ANCOVA comparing the amygdala
volumes of patients with and without PTSD and controls and
adjusting for total brain volume yielded a significant effect of
group, indicating smaller amygdala volumes of trauma-
 exposed patients (Table 2). The post-hoc 2 × 2 (group × hemi-
sphere) ANCOVA for each trauma-exposed group and the
control group confirmed these results (PTSD v. controls:
F1,32 = 46.2, p < 0.001; non–PTSD v. controls: F1,36 = 15.2,
p < 0.001). Patients with and without PTSD did not differ sig-
nificantly (F1,21 = 1.3, p = 0.28).
The overall 3 × 2 (group × hemisphere) ANCOVA compar-
ing the hippocampus volumes of patients with and without
PTSD and controls and adjusting for total brain volume also
yielded a significant effect of group, indicating smaller hip-
pocampus volumes of trauma-exposed patients (Table 2).
The post-hoc 2 × 2 (group × hemisphere) ANCOVA for each
trauma-exposed group and the control group confirmed
these results (PTSD v. controls: F1,32 = 9.3, p = 0.005; non-PTSD
v. controls: F1,36 = 9.0, p = 0.005). Patients with and without
PTSD did not differ significantly (F1,21 = 0.0, p = 0.97).
We repeated ANCOVA testing amygdala and hippocam-
pus volumes while introducing IQ (WAIS-R) as a further co-
variate. The results of all analyses remained the same, except
for the comparison of hippocampus volumes across the
group with PTSD and controls, which did not yield a signifi-
cant effect of group (F1,31 = 2.4, p = 0.14). Results of our 1-way
ANCOVA across these 2 groups were also not significant
(left hippocampus: F1,31 = 0.6, p = 0.44; right hippocampus:
F1,31 = 3.3, p = 0.08).
Neuropsychological results
Compared with controls, patients with PTSD were signifi-
cantly impaired on all intellectual and mnemonic measures
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Table 2: Morphometric measures of trauma-exposed patients with borderline personality disorder with or without posttraumatic stress disorder and
healthy controls
Group; mean (SD)*
Variable BPD with PTSD (n = 10) BPD without PTSD (n = 14) Controls (n = 25) Statistical test p value
Height, cm 168 (5) 166 (6) 169 (6) F2,46 = 1.1 0.35
Intracranial volume, mL 1326 (115) 1419 (76) 1384 (88) F2,46 = 2.9 0.07
Total brain volume, mL† 1027 (94)¶ 1121 (69) 1106 (81) F2,45 = 6.3 0.004
Brain:skull ratio, % 77 (2)** 79 (2) 80 (2) F2,46 = 7.6 0.001
Amygdala‡
Left, mL 0.72 (0.19)†† 0.90 (0.27)‡‡ 1.12 (0.15) F2,45 = 13.1 < 0.001
ANCOVA adjusted means
(% difference in regional
volume relative to controls)
0.74 (–33.6) 0.89 (–22.2) 1.11
Right, mL 0.77 (0.14)†† 0.89 (0.24)†† 1.15 (0.16) F2,45 = 17.9 < 0.001
ANCOVA adjusted means
(% difference in regional
volume relative to controls)
0.76 (–34.2) 0.89 (–22.3) 1.15
Hippocampus§
Left, mL 2.49 (0.41) 2.68 (0.37)§§ 2.95 (0.43) F2,45 = 4.0 0.025
ANCOVA adjusted means
(% difference in regional
volume relative to controls)
2.65 (–9.5) 2.61 (–10.7) 2.93
Right, mL 2.54 (0.46)‡‡ 2.84 (0.43)‡‡ 3.16 (0.35) F2,45 = 7.5 0.002
ANCOVA adjusted means
(% difference in regional
volume relative to controls)
2.68 (–14.5) 2.78 (–11.1) 3.13
ANCOVA = analysis of covariance; BPD = borderline personality disorder; PTSD = posttraumatic stress disorder; SD = standard deviation.
*Unless otherwise indicated.
†One-way ANCOVA controlling for intracranial volume.
‡The overall 3 × 2 (group × hemisphere) ANCOVA using total brain volume as covariate had the following F values: group, F2,45 = 18.0, p < 0.001; hemisphere, F2,45 = 3.0, p = 0.09;
group × hemisphere, F2,45 = 0.3, p = 0.754.
§The overall 3 × 2 (group × hemisphere) ANCOVA using total brain volume as covariate had the following F values: group, F2,45 = 7.4, p = 0.002; hemisphere, F2,45 = 0.5, p = 0.50;
group × hemisphere, F2,45 = 0.7, p = 0.497.
¶Significantly different from controls (p < 0.001; 1-way ANCOVA controlling for intracranial volume).
**Significantly different from controls (p < 0.001; post-hoc test).
††Significantly different from controls (p < 0.001; 1-way ANCOVA controlling for total brain volume).
‡‡Significantly different from controls (p < 0.01; 1-way ANCOVA controlling for total brain volume).
§§Significantly different from controls (p < 0.05; 1-way ANCOVA controlling for total brain volume).
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applied except verbal memory and delayed recall (WMS-R)
and TMT part B (Table 1). In contrast, trauma-exposed pa-
tients without PTSD were unimpaired. Accordingly, patients
with PTSD had lower test scores than those without PTSD,
reaching statistical significance for most mnemonic and
 attentional measures applied (Table 1).
We entered the left- and right-sided amygdala and hip-
pocampus volumes and total brain volumes of trauma-
 exposed patients into multiple regression analyses. Perfor-
mance IQ (R2 = 0.261, p = 0.011), attention/concentration
(WMS-R; R2 = 0.319, p = 0.004) and part B of the TMT
(R2 = 0.217, p = 0.022) were significantly predicted by right
hippocampus volume, indicating better test performance in
patients with larger hippocampus volumes. All other predic-
tors did not reach the inclusion criterion of α = 0.05.
Discussion
We found 12% hippocampus size reduction in patients with
BPD and PTSD and an 11% reduction in those without PTSD.
Our results are well matched to those of previous studies,8–12
reporting about 10%–20% hippocampus size reduction in pa-
tients with BPD compared with healthy controls. Our results
further indicate that hippocampus size of trauma-exposed
patients with BPD but without PTSD was significantly re-
duced compared with healthy controls. So far, one previous
study8 applied a similar test design to ours and reached simi-
lar results.
Results concerning amygdala size reduction in patients
with BPD are equivocal. We found an enormous amygdala
size reduction in patients with BPD and PTSD (34%) and, to a
somewhat lesser degree, in those without PTSD (22%). To
our knowledge, 5 previous studies investigated amygdala
size in patients with BPD, with 2 studies reporting only
 minor or no amygdala size reduction8,28 and 3 studies9–11
 reporting strong amygdala size reduction (about 15%–25%).
We suppose that differing sample characteristics are respon-
sible for the heterogeneous results. All studies so far used
mixed samples, including patients with and without trau-
matic exposure and with and without PTSD.
Studies on amygdala size in patients with PTSD but with-
out BPD are also rare. A recent meta-analysis2 demonstrated
minor amygdala size reduction in patients with PTSD and no
amygdala size reduction in trauma-exposed patients without
PTSD. Thus, from the presently available data, it may be
speculated that BPD, irrespective of traumatic exposure or
subsequent development of PTSD, has a negative impact on
amygdala size. However, studies investigating patients with
BPD but without trauma exposure are needed to firmly test
this assumption.
It also seems likely that the traumatic stress itself exerted
some adverse effects on the brains of our patients with BPD.
Previous studies have already found significant relations
between severity of traumatic exposure and severity of hip-
pocampus size reduction.4,6,8 Accordingly, recent meta-
 analyses on PTSD1,2 found that hippocampus size differ-
ences across studies were smaller when comparing patients
with PTSD and trauma-exposed controls and larger when
comparing patients with PTSD and healthy controls.
So far, cognitive deficits have been repeatedly reported for
patients with PTSD.3–7 Studies comparing trauma-exposed
patients with and without PTSD yielded better cognitive per-
formance of patients without PTSD; however, these differ-
ences mostly failed to reach statistical significance.4,6,7,29 The
same is true for the present study. Across participants, worse
cognitive performance was significantly related to smaller
right hippocampus size. Previous studies have already
demonstrated relations between hippocampus size reduction
and cognitive deficits among individuals who had been ex-
posed to traumatic stress,3–5,7,12 suggesting that hippocampal
damage may be a powerful predictor of cognitive deficits in
patients having been exposed to traumatic stress.
Total brain volumes of our trauma-exposed patients with
PTSD were decreased, and the amount of global atrophy
(brain:skull ratio) increased. Individuals with BPD or PTSD
have been reported to have an increased prevalence of subtle
neurologic impairment and brain insults.30,31 Head trauma
may be associated with physical abuse and might be respon-
sible for the behavioural and brain abnormalities of patients
with BPD and PTSD rather than the disease itself. However,
ANCOVA controlling for total brain volume indicated signif-
icant differences in regional brain volumes between patients
with PTSD and controls. Furthermore, we excluded patients
with a history of neurologic disease. Nevertheless, future
studies should make any effort to gather information on the
nature of physical abuse that participants experienced.
Limitations
A limitation of our study is that sample sizes of trauma-
 exposed groups were relatively small. Larger sample sizes
may have revealed statistically significant differences of
amygdala size between patients with and without PTSD.
Our trauma-exposed patients had lower IQs than controls.
Present evidence suggests that hippocampus size accounts
for a modest proportion of the variance in human intelli-
gence,32 leaving open the possibility that the small hippocam-
pus size of our patients with PTSD was related to pre-
 existing low intelligence rather than to PTSD or BPD. This
assumption is supported by the finding of low precombat in-
telligence as a risk factor for PTSD developing in combat vet-
erans.33 Performance IQ of our trauma-exposed patients was
significantly predicted by right hippocampus volumes, and
our ANCOVA comparing hippocampus volumes across our
patients with PTSD and controls and adjusting for total brain
volume and IQ failed to reveal a significant effect of group.
Nevertheless, our study design does not allow deciding
whether hippocampus size reduction in our trauma-exposed
patients was the cause or result of their lower IQs.
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